In the first quarter of 2026, a notable shift occurred in the investment portfolios of two influential financial entities: Warren Buffett's Berkshire Hathaway completely divested from UnitedHealth Group (UNH), while David Tepper's Appaloosa Management substantially trimmed its stake in the same healthcare giant. This synchronized departure by highly respected investors prompts a deeper examination, especially considering that many sell-side analysts continue to hold positive ratings for UNH, with a consensus price target of $407.38 and a strong majority of 'buy' or 'strong buy' recommendations.
The decision by these investment powerhouses to exit or reduce their positions in UNH warrants scrutiny, despite the company's seemingly robust first-quarter 2026 performance, which saw adjusted earnings per share surpass expectations and revenue reach $111.72 billion. However, a closer look reveals that this improved performance was partly driven by a strategy of reducing its Medicare Advantage member base, with a loss of nearly a million members in Q1 2026 alone, and a projected further reduction of 2.3 to 2.8 million members through the discontinuation of unprofitable contracts. This approach, while boosting margins, differs significantly from growth achieved through pricing power, suggesting a more defensive stance by the company.
Several impending challenges likely influenced these major investors' decisions. Firstly, preliminary 2027 Medicare Advantage rate adjustments were less favorable than anticipated. Secondly, a federal report highlighted UnitedHealth's disproportionately high post-hospital care denial rates, ranging from 51% to 80% in its Medicare Advantage plans, far exceeding those of its competitors. This has led to consequences, such as Fairview Health Services' announcement to cease accepting UnitedHealthcare Medicare Advantage in 2027, impacting thousands of patients. Lastly, the profitability recovery of Optum Health, a subsidiary, has been slower than market expectations, with first-quarter operating earnings lagging behind the previous year. These factors collectively paint a picture of mounting pressures that could impact UNH's future financial performance and market standing.
The concerted withdrawal by these leading investors serves as a crucial signal for those managing retirement portfolios, emphasizing the importance of scrutinizing underlying assumptions in bullish investment theses. While institutional exits aren't always a definitive verdict on a company's health, they indicate that sophisticated investors perceive risks in the prevailing market narrative. For long-term investors, this situation underscores the need to assess whether the company's recovery trajectory and future profitability are sustainable amidst evolving regulatory landscapes and operational challenges, rather than merely mirroring the actions of billionaires.
